Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674037 | SCV000799308 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-04-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868275 | SCV002238872 | pathogenic | not provided | 2020-12-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val874*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 557846). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003453375 | SCV004182423 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453374 | SCV004182424 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing |